Knight Therapeutics LATAM

📍 Montevideo, Uruguay👥 124 employees💰 Last funded Jan 2016
Biotechnology🌐 grupobiotoscana.com
Website LinkedIn
We are the first Latin American biopharmaceutical company based on innovation. We develop, manufacture and commercialize advanced medicines, aimed at treating truly unmet medical needs. Headquartered in Montevideo, Uruguay and with presence in 10 countries throughout the region, GBT offers an unparalleled infrastructure among its peers. We are a team of more than 600 scientists, doctors, pharmacists, regulatory professionals, sales and marketing experts, access specialists and dedicated support people spread throughout the region who make their lives'​ purpose to enhance lives and restore hopes to patients with severe and debilitating conditions. We focus on products that make a difference for doctors'​ practices and transform lives in profound and meaningful ways. Our main areas of operations are oncology and, onco-hematology, severe infectious diseases, specialty treatments, immunology and inflammation and orphan and rare diseases. GBT embraces Open Innovation at its core. A large portion of GBT's pipeline is sourced by partnering with biotechnology and other pharmaceutical companies worldwide. We complement this process with our own proprietary R&D efforts to drive strong R&D productivity and deliver truly innovative therapies that transform lives and restore hopes across the Latin American region. As a result, GBT's portfolio of medicines is comprised of truly cutting-edge technology that makes a difference for more than 200,000 doctors and more than 800,000 patients every year. Patients that can aspire to receive the benefits of truly modern medicine and, more importantly, to live longer and more meaningful lives.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Colombia
1
Uruguay
1
Frequently asked questions
Who invested in Knight Therapeutics LATAM?
Knight Therapeutics LATAM has 2 investors on record on gritt.io.
When did Knight Therapeutics LATAM last raise funding?
The most recent investment in Knight Therapeutics LATAM recorded on gritt.io was in January 2016.
What industry is Knight Therapeutics LATAM in?
Knight Therapeutics LATAM operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Knight Therapeutics LATAM based?
Knight Therapeutics LATAM is headquartered in Montevideo, Uruguay.